ReviewIndian journal of microbiology2017
Bedaquiline: Fallible Hope Against Drug Resistant Tuberculosis.
Review in Indian journal of microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.
- Prevalence of bedaquiline resistance in patients with drug-resistant tuberculosis: a systematic review and meta-analysis.BMC infectious diseases · 2025Pooled it
- A systematic review of economic evaluations of pharmacological treatments for active tuberculosis.Frontiers in public health · 2024Pooled it
- Plastic film biodegradation using Stutzerimonas stutzeri with metal nanoparticles as degradation enhancers-A bioeconomic approach.Biodegradation · 2025Article
- The Biological Characteristics ofInternational journal of molecular sciences · 2024Article
- A Narrative Review of Bedaquiline and Delamanid: New Arsenals Against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis.Journal of clinical laboratory analysis · 2024Review
- Genome analyses of 174 strains ofMicrobial genomics · 2021Article
- Alginate-Capped Silver Nanoparticles as a Potent Anti-mycobacterial Agent AgainstFrontiers in pharmacology · 2021Article
- Prediction of Transcription Factors and Their Involvement in Regulating Rifamycin Production inIndian journal of microbiology · 2020Article
- Identification of pyrrolo-pyridine derivatives as novel class of antibacterials.Molecular diversity · 2020Article
- Article
- Infection and Microbiome: Impact of Tuberculosis on Human Gut Microbiome of Indian Cohort.Indian journal of microbiology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberculosis (TB) is a deadly bacterial infectious disease caused by intra-cellular pathogen
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.